SPARC and metabolic dysfunction-associated steatotic liver disease: In particular we tested the hypothesis that SPARC is elevated under conditions of necrosis and inflammation, and could be associated with a high risk of fibrosis in obesity-related human liver disease and animal models mimicking NAFLD/NASH.